Clinical Trials

  • Clinical Trials: Design, Conduct, and Analysis
    By Curtis L. Meinert, Susan Tonascia

    Mather HG , Pearson NG , Read KLQ , Steed GR , Thorne MG , Jones S , Guerrier CJ , Eraut 2 CD , McHugh PM , Chowdhury NR , Jafary MH , Wallace TJ : Acute myocardial infarction : Home and hospital treatment .

  • Clinical Trials: A Methodologic Perspective
    By Steven Piantadosi

    S. D. Walter. Methods of reporting statistical results from medical research studies. American Journal of Epidemiology, 141(10):896–906, 1995. S. D. Walter and N. E. Day. Estimation of the duration of a pre-clinical disease state using ...

  • Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
    By Tom Brody

    Guidance for industry. Good pharmacovigilance practices and pharmacoepidemiologic assessment; March 2005 (20 pp.). 1Kotterman MA, Schaffer DV. Engineering adeno-associated viruses for clinical gene CLINICAL TRIALS 568 25.

  • Clinical Trials: A Methodologic Perspective
    By Steven Piantadosi

    S. Greenland. Quantitative methods in the review of epidemiologic literature. Epidemiologic Reviews, 9:1–30 ... P. Greenwald, K. M. Witkin, W. F. Malone, D. P. Byar, L. S. Freedman, and H. R. Stern. The study of markers of biological ...

  • Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
    By Tom Brody

    Kirkwood and Sterne (80) provide the same sort of calculation in an example involving two samples.The first sample is an experimental group (Group 1; 36 smokers), while the second sample is a control group (Group 0; 64 non-smokers).

  • Clinical Trials
    By Timothy M. Pawlik, Julie A. Sosa

    American College of Surgeons Clinical Research Program, Alliance for Clinical Trials in Oncology, Nelson HD, Hunt KK. Operative standards for cancer surgery, volume i: breast, lung, pancreas, colon. Philadelphia, PA: Wolters Kluwer ...

  • Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
    By Tom Brody

    This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, HRQoL, consent forms and package inserts.

  • Clinical Trials: A Practical Guide to Design, Analysis, and Reporting
    By Duolao Wang, Ameet Bakhai

    This book explains statistics specifically for a medically literate audience. Readers gain not only an understanding of the basics of medical statistics, but also a critical insight into how to review and evaluate clinical trial evidence.

  • Clinical Trials: A Methodologic Perspective
    By Steven Piantadosi

    CRM – Implements the continual reassessment methods for dose finding clinical trials. OPTIMAL – Calculates two-stage optimal phase II designs using the Simon method. POWER – This is a power and sample size program for clinical trials.

  • Clinical Trials: A Practical Approach
    By Stuart J. Pocock

    "This book succeeds admirably in this aim and is accessible to a wide audience, including clinical investigators, statisticians, and those involved in data management and the administration of clinical trials." —Controlled Clinical Trials ...

  • Clinical Trials: A Methodologic Perspective
    By Steven Piantadosi

    This text distinguishes itself with its accessible and broad coverage of statistical design methods--the crucial building blocks of clinical trials and medical research.

  • Clinical Trials: A Practical Approach
    By Stuart J. Pocock

    "This book succeeds admirably in this aim and is accessible to a wide audience, including clinical investigators, statisticians, and those involved in data management and the administration of clinical trials." —Controlled Clinical Trials ...

  • Clinical Trials: What Patients and Volunteers Need to Know
    By Ph.d, Lorna Speid

    A vital resource for those who are considering enrolling in a clinical trial, or for the parents, friends, or relatives of those involved in a clinical trial, this book takes away the mystery and allows the participant to enter a clinical ...